UTHR
United Therapeutics Corporation
NASDAQHealthcareBiotechnologyUS
Rating:A-
Company Profile
CEO
Martine A. Rothblatt
IPO Date
1999-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
United Therapeutics Corporation
CEO
Martine A. Rothblatt
IPO Date
1999-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 80 |
| $527.31 |
| 17 Jul 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 1,400 | $528.42 |
| 17 Jul 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 3,057 | $529.46 |
| 17 Jul 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 1,924 | $530.14 |
| 17 Jul 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 520 | $532.14 |
| 17 Jul 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 440 | $533.28 |
| 17 Jul 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 1,198 | $534.31 |
| 17 Jul 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 720 | $535.20 |
| 17 Jul 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 150 | $536.29 |
| 18 Apr 2022 | Michael McCaul | Michael McCaul | Purchase | $15,001 - $50,000 |
| 18 Apr 2022 | Michael McCaul | Michael McCaul | Purchase | $1,001 - $15,000 |
| 23 Feb 2022 | Michael McCaul | Michael McCaul | Sale | $1,001 - $15,000 |
| 23 Feb 2022 | Michael McCaul | Michael McCaul | Sale | $15,001 - $50,000 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Sale (Full) | $1,001 - $15,000 |